Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: 2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES) [Phase 2]
Phase 2 trial evaluating cladribine (2-Chlorodeoxyadenosine) in combination with cytarabine for idiopathic hypereosinophilic syndrome has co…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS [Phase 1, Phase 2]
The study reports pharmacokinetic evaluation of rasburicase in patients with leukemia or lymphoma who are at high risk of tumor lysis syndro…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: FTS Study in Patients With Advanced Hematologic Malignancies [Phase 1]
Phase I study update of FTS in patients with advanced hematologic malignancies, including myelodysplastic syndromes and leukemia; the trial …
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients [NA]
A completed study assessing the use and tolerability of imatinib mesylate (Gleevec) in patients with leukemia.
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 study evaluating weekly clofarabine for relapsed/refractory chronic lymphocytic leukemia has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Oral Valganciclovir Versus Valacyclovir [Phase 2]
A Phase 2 clinical trial comparing oral valganciclovir versus valacyclovir in patients with chronic lymphocytic leukemia and leukemia, which…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating decitabine with peripheral stem cell transplantation in patients relapsed after bone marrow transplantat…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) [Phase 1]
This report notes the completion of a Phase 1 clinical trial evaluating azacitidine as maintenance therapy after allogeneic bone marrow tran…
-
CLINICAL_TRIALS withdrawal · 2012-07-30Clinical Trial Update: NOV-002 in Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial of NOV-002 in myelodysplastic syndrome has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: 2 Arm Study of Clofarabine IV in MDS Patients [Phase 2]
Phase 2 trial evaluating intravenous Clofarabine in patients with myelodysplastic syndrome and leukemia has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia [Phase 1]
Phase 1 trial of dasatinib in children and adolescents with relapsed or refractory leukemia has completed with results posted in 2012.
-
CLINICAL_TRIALS other · 2012-07-23Clinical Trial Update: Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes [Phase 1]
Phase 1 trial update showing termination of the study evaluating OPB-31121 in advanced leukemias and myelodysplastic syndromes.
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: A Phase I Trial of ZIO-101 in Hematologic Cancers [Phase 1]
This document reports the completion status of a Phase I trial evaluating ZIO-101 in hematologic cancers sponsored by Alaunos Therapeutics.
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation after conditioning with busulfan, fludarabine, and antithymocyte globuli…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML [Phase 2]
Phase 2 trial investigating chemotherapy, total-body irradiation, donor NK cell infusion, Aldesleukin, and umbilical cord blood transplant f…
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions [Phase 1]
Phase 1 clinical trial update on HLA Class I haplotype-mismatched natural killer cell infusions for hematologic cancers, including lymphoma,…
-
CLINICAL_TRIALS withdrawal · 2012-06-20Clinical Trial Update: Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia [Phase 1]
A Phase 1 trial of recombinant human Mannose-Binding Lectin (MBL) in young patients with MBL deficiency and fever with neutropenia was withd…
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial investigating donor stem cell or donor white blood cell infusions in hematologic cancers; the study is terminated with results…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for a treatment regimen of radiation therapy and chemotherapy followed by peripheral st…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation [Phase 2]
Phase 2 trial of peripheral blood lymphocyte therapy using EBV-specific cytotoxic T cells to prevent EBV-related lymphoproliferative disorde…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a phase 1/2 study evaluating peripheral stem cell transplantation in patients with brea…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial update evaluating stem cell transplantation as treatment for hematologic cancers. The study includes patients with various hem…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 clinical trial update on bone marrow and peripheral stem cell transplantation for patients with hematologic cancers; the study statu…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders [NA]
Clinical trial update for a study evaluating G-CSF–treated donor bone marrow transplant in hematologic disorders; the trial (NCT00253552) is…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies [Phase 2]
Phase 2 clinical trial evaluating natural killer (NK) cell adback after allogeneic stem cell transplant with Campath-IH plus chemoradiation …